| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Ann Beal Salamone is Director at SMTI. Ann Beal Salamone's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $864K at current prices.
Ann Beal Salamone has 9 Form 4 filings on record from January 2020 to June 2026, all as Director at Sanara MedTech (SMTI), 2020–2026.
The 11 reported transactions were 10 stock awards and 1 other transaction.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria